121 related articles for article (PubMed ID: 11101198)
1. The effect of mibefradil on ischemic episodes with and without increase in heart rate.
Tzivoni D; Gilula Z; Klutstein MW; Reisin L; Botvin S; Kobrin I
Cardiovasc Drugs Ther; 2000 Oct; 14(5):503-9. PubMed ID: 11101198
[TBL] [Abstract][Full Text] [Related]
2. Effects of a new calcium antagonist, mibefradil (Ro 40-5967), on silent ischemia in patients with stable chronic angina pectoris: a multicenter placebo-controlled study. The Mibefradil International Study Group.
Braun S; van der Wall EE; Emanuelsson H; Kobrin I
J Am Coll Cardiol; 1996 Feb; 27(2):317-22. PubMed ID: 8557900
[TBL] [Abstract][Full Text] [Related]
3. Antianginal and anti-ischemic effects of mibefradil in the treatment of patients with chronic stable angina pectoris.
Alpert JS; Bakx AL; Braun S; Frishman WH; Schneeweiss A; Tzivoni D; Kobrin I
Am J Cardiol; 1997 Aug; 80(4B):20C-26C. PubMed ID: 9286850
[TBL] [Abstract][Full Text] [Related]
4. T-type calcium channel blockade in the management of chronic ischemic heart disease.
Marsh JD; Antman EM
Cardiovasc Drugs Ther; 2000 Oct; 14(5):459-61. PubMed ID: 11101192
[TBL] [Abstract][Full Text] [Related]
5. Randomized comparison of T-type versus L-type calcium-channel blockade on exercise duration in stable angina: results of the Posicor Reduction of Ischemia During Exercise (PRIDE) trial.
Lee DS; Goodman S; Dean DM; Lenis J; Ma P; Gervais PB; Langer A;
Am Heart J; 2002 Jul; 144(1):60-7. PubMed ID: 12094189
[TBL] [Abstract][Full Text] [Related]
6. Anti-anginal and anti-ischemic effects of mibefradil, a new T-type calcium channel antagonist.
Kobrin I; Bieska G; Charlon V; Lindberg E; Pordy R
Cardiology; 1998; 89 Suppl 1():23-32. PubMed ID: 9570426
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of mibefradil compared with amlodipine in suppressing exercise-induced and daily silent ischemia: results of a multicenter, placebo-controlled trial.
Tzivoni D; Kadr H; Braat S; Rutsch W; Ramires JA; Kobrin I
Circulation; 1997 Oct; 96(8):2557-64. PubMed ID: 9355894
[TBL] [Abstract][Full Text] [Related]
8. Combination of calcium channel blockers and beta blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. The Netherlands Working Group on Cardiovascular Research (WCN).
van der Vring JA; Daniëls MC; Holwerda NJ; Withagen PJ; Schelling A; Cleophas TJ; Hendriks MG
Angiology; 1999 Jun; 50(6):447-54. PubMed ID: 10378820
[TBL] [Abstract][Full Text] [Related]
9. The angiographic and clinical benefits of mibefradil in the coronary slow flow phenomenon.
Beltrame JF; Turner SP; Leslie SL; Solomon P; Freedman SB; Horowitz JD
J Am Coll Cardiol; 2004 Jul; 44(1):57-62. PubMed ID: 15234407
[TBL] [Abstract][Full Text] [Related]
10. Additional antianginal and anti-ischemic efficacy of mibefradil in patients concomitantly treated with long-acting nitrates for chronic stable angina pectoris.
Frishman WH; Bittar N; Glasser S; Habib G; Smith W; Pordy R
Clin Cardiol; 1998 Jul; 21(7):483-90. PubMed ID: 9669057
[TBL] [Abstract][Full Text] [Related]
11. Combination of calcium channel blockers and beta-blockers for patients with exercise-induced angina pectoris: beneficial effect of calcium channel blockers largely determined by their effect on heart rate.
Cleophas TJ; van der Sluijs J; van der Vring JA; Daniëls MC; Holwerda KJ; Withagen AJ; Schelling A; Hendriks MG; Zwinderman AH
J Clin Pharmacol; 1999 Jul; 39(7):738-46. PubMed ID: 10392329
[TBL] [Abstract][Full Text] [Related]
12. Mibefradil in the treatment of chronic stable angina pectoris: comparative studies with other calcium antagonists.
Davies GJ; Tzivoni D; Kobrin I
Am J Cardiol; 1997 Aug; 80(4B):34C-39C. PubMed ID: 9286852
[TBL] [Abstract][Full Text] [Related]
13. Effect of nipradilol on silent myocardial ischemia and heart rate variability in chronic stable angina.
Takase B; Hikita H; Satomura K; Mastui T; Ohsuzu F; Kurita A
Cardiovasc Drugs Ther; 2002 Jan; 16(1):43-51. PubMed ID: 12085977
[TBL] [Abstract][Full Text] [Related]
14. Combination of calcium channel blockers and beta-adrenoceptor blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. Netherlands Working Group on Cardiovascular Research (WCN).
Van Der Vring JA; Daniëls MC; Holwerda NJ; Withagen PJ; Schelling A; Cleophas TJ; Hendriks MG
Br J Clin Pharmacol; 1999 May; 47(5):493-8. PubMed ID: 10336572
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of the antiischemic effect of mibefradil, a selective T calcium channel blocker in dogs: comparison with amlodipine.
Roux S; Bühler M; Clozel JP
J Cardiovasc Pharmacol; 1996 Jan; 27(1):132-9. PubMed ID: 8656647
[TBL] [Abstract][Full Text] [Related]
16. Additional antianginal and anti-ischemic efficacy of mibefradil in patients pretreated with a beta blocker for chronic stable angina pectoris.
Alpert JS; Kobrin I; DeQuattro V; Friedman R; Shepherd A; Fenster PE; Thadani U
Am J Cardiol; 1997 Apr; 79(8):1025-30. PubMed ID: 9114758
[TBL] [Abstract][Full Text] [Related]
17. Subsets of ambulatory myocardial ischemia based on heart rate activity. Circadian distribution and response to anti-ischemic medication. The Angina and Silent Ischemia Study Group (ASIS).
Andrews TC; Fenton T; Toyosaki N; Glasser SP; Young PM; MacCallum G; Gibson RS; Shook TL; Stone PH
Circulation; 1993 Jul; 88(1):92-100. PubMed ID: 8319361
[TBL] [Abstract][Full Text] [Related]
18. Mibefradil, a T-type channel-selective calcium antagonist: clinical trials in chronic stable angina pectoris.
Massie BM
Am J Hypertens; 1998 Apr; 11(4 Pt 3):95S-102S. PubMed ID: 9607373
[TBL] [Abstract][Full Text] [Related]
19. Mibefradil, a pharmacologically distinct calcium antagonist.
Ernst ME; Kelly MW
Pharmacotherapy; 1998; 18(3):463-85. PubMed ID: 9620098
[TBL] [Abstract][Full Text] [Related]
20. Increased blood pressure and neural tone in the silent ischemia of hypertension: disparate effects of immediate release nifedipine.
Lee DD; Rigonan K; Dequattro V
J Am Coll Cardiol; 1993 Nov; 22(5):1438-45. PubMed ID: 8227803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
